Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

964
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
964
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

750
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
750
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

888
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macular Layer Thickness with Spectral-Domain and High-Resolution OCT.

Ophthalmology science·2026
Same author

Assessing referral quality in glaucoma care: a retrospective analysis of clinical data in optometrist and ophthalmologist referrals.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Value of 10-2 Visual Field Testing for Detecting Progression in Patients with Glaucoma.

Ophthalmology·2026
Same author

A hybrid framework for effective microscopic cell counting segmentation integrating Light-U-net with watershed.

Experimental eye research·2026
Same author

Machine learning for frailty assessment and outcome prediction in cardiovascular disease: A scoping review.

Ageing research reviews·2026
Same author

Impact of ageing on progressive thinning of the retinal nerve fibre layer in glaucoma.

The British journal of ophthalmology·2026

Related Experiment Video

Updated: Oct 15, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K

Comparing Five Criteria for Evaluating Glaucomatous Visual Fields.

Herman Stubeda1, Jack Quach2, Jennifer Gao2

  • 1Dalhousie University Medical School, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Ophthalmology and Visual Sciences, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

American Journal of Ophthalmology
|October 25, 2021
PubMed
Summary

No single test best detects glaucoma visual field damage. Different criteria like Glaucoma Hemifield Test (GHT) and Hoddap-Anderson-Parrish 2 (HAP2) offer varying sensitivity and specificity for glaucoma evaluation.

More Related Videos

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
07:45

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Published on: July 21, 2020

4.6K
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

763

Related Experiment Videos

Last Updated: Oct 15, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K
Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
07:45

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Published on: July 21, 2020

4.6K
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

763

Area of Science:

  • Ophthalmology
  • Medical Diagnostics

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Accurate assessment of glaucomatous visual field (VF) damage is crucial for timely intervention.
  • Current criteria for evaluating VF damage lack a universally agreed-upon best method.

Purpose of the Study:

  • To compare the diagnostic performance (sensitivity and specificity) of five common criteria for evaluating glaucomatous visual field damage.
  • To assess these criteria across different levels of functional and structural glaucoma progression.

Main Methods:

  • Retrospective cross-sectional study of 1230 patients with suspect or known glaucoma.
  • Utilized Humphrey 24-2 visual field and Spectralis OCT data.
  • Developed an OCT score based on optic nerve head and retinal nerve fiber layer thickness abnormalities.
  • Inferred sensitivity and specificity based on positive rates in patients with low versus higher glaucomatous damage.

Main Results:

  • No single criterion demonstrated uniformly superior performance across all damage levels.
  • For early or mild glaucoma, Glaucoma Hemifield Test (GHT), Foster, and Low-pressure Glaucoma Treatment Study (LoGTS) showed higher specificity.
  • For more advanced glaucoma, Hoddap-Anderson-Parrish 2 (HAP2) and United Kingdom Glaucoma Treatment Study (UKGTS) exhibited higher sensitivity.

Conclusions:

  • The choice of visual field testing criterion should be tailored to the clinical context.
  • Consideration should be given to the anticipated level of glaucomatous damage and the desired balance between sensitivity and specificity.